F S&P 500
5,105.25 +13.75 (+0.27%) F Dow Jones
38,610.00 +228.00 (+0.59%) F Nasdaq
17,756.00 +106.25 (+0.60%) E-mini Russell 2000 Index Futur
2,023.60 -3.60 (-0.18%) Petróleo
79.16 +0.21 (+0.27%) Oro
2,315.70 +6.10 (+0.26%)
OptimizeRx Corporation (OPRX)
Fuera de horario:
OptimizeRx Corporation
260 Charles Street
Suite 302
Waltham, MA 02453
United States
248-651-6568
https://www.optimizerx.com
Sector(es): Healthcare
Industria: Health Information Services
Empleados a tiempo completo: 135
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. William J. Febbo | CEO & Director | 694.4k | N/D | 1969 |
| Mr. Stephen L. Silvestro | President | 458.6k | N/D | 1978 |
| Mr. Edward Stelmakh C.M.A., M.B.A. | CFO & COO | 547.05k | N/D | 1966 |
| Mr. Andrew Jacob D'Silva | Senior Vice President of Corporate Finance | N/D | N/D | N/D |
| Mr. Todd Inman | Chief Technology Officer | N/D | N/D | 1956 |
| Ms. Marion K Odence-Ford | General Counsel & Chief Compliance Officer | 428.12k | N/D | 1965 |
| Maira Alejandra | Media Relations Manager | N/D | N/D | N/D |
| Ms. Sheryl Kearney | Human Resources Manager | N/D | N/D | N/D |
| Mr. Terence J. Hamilton | Senior Vice President of Pharma | 441.63k | N/D | 1965 |
| Dr. Doug Besch | Chief Product Officer | N/D | N/D | 1982 |
Descripción
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.
Gestión corporativa
La calificación ISS Governance QuickScore de OptimizeRx Corporation a partir del 1 de mayo de 2024 es 9. Las puntuaciones principales son Auditoría: 10; Junta: 6; Derechos del accionista: 4; Compensación: 10.
